Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

184
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
184
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

195
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
195
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

257
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
257
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

249
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

258
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

18.4K
z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
18.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal multiomics profiling of extracorporeal cross-circulation with pig liver xenografts in human decedents.

Nature medicine·2026
Same author

Gut microbiota in a Saudi population with chronic kidney disease.

World journal of nephrology·2026
Same author

Association of Toll-like receptor gene polymorphisms with susceptibility to hepatitis B virus-related acute-on-chronic liver failure: a case-control study.

Scientific reports·2026
Same author

Interfacial Redox Decoupling via Amphiphilic Carbon Dots for Highly Efficient Biphasic Photocatalytic H<sub>2</sub>O<sub>2</sub> Production and Selective Benzyl Alcohol Oxidation.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Hollow MnO<sub>2</sub> nanosystem for glioblastoma sono-immunotherapy based on blood-brain barrier crossing and oxygen supply strategy.

Journal of colloid and interface science·2026
Same author

Microbial ecology and flavor formation mechanisms of high-temperature Daqu in the Huang-Huai River basin and adjacent regions: A comparative study from eastern Henan, Jiaodong peninsula, and southern Anhui.

Food research international (Ottawa, Ont.)·2026

Related Experiment Video

Updated: Jan 18, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.4K

Easy-to-use nomogram to predict neonatal hyperbilirubinemia.

Shanshan Wang1, Chan Wang1, Siqi Zheng2

  • 1Department of Pediatrics, The Second Hospital of Dalian Medical University, Dalian, China.

Peerj
|September 12, 2025
PubMed
Summary

This study developed a nomogram to predict neonatal hyperbilirubinemia risk. The tool identified key factors like gestational age and birth weight, offering early identification for at-risk newborns.

Keywords:
HyperbilirubinemiaNeonateNomogramNon-invasive testPredictive model

More Related Videos

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.4K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.6K

Related Experiment Videos

Last Updated: Jan 18, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.4K
Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

3.4K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.6K

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Medical Informatics

Background:

  • Neonatal hyperbilirubinemia is a frequent cause of newborn hospitalization.
  • Early identification of infants at risk is crucial for timely intervention.
  • This study aimed to identify risk factors and develop a predictive tool.

Purpose of the Study:

  • To explore risk factors associated with neonatal hyperbilirubinemia.
  • To construct and validate an easy-to-use nomogram for early prediction.
  • To improve early detection and management of hyperbilirubinemia in newborns.

Main Methods:

  • Retrospective study of 646 neonates.
  • Data split into training (454) and validation (192) sets.
  • Least Absolute Shrinkage and Selection Operator (LASSO) regression used to identify predictors.
  • Nomogram performance evaluated using ROC curves, calibration curves, and DCA.

Main Results:

  • Six independent risk factors identified: gestational age, birth weight, PROM or maternal fever, blood type incompatibility, probiotic supplementation, and significant weight loss.
  • The nomogram demonstrated good predictive accuracy (AUCs 0.825 and 0.829).
  • Calibration curves showed close agreement between predicted and observed values.

Conclusions:

  • The developed nomogram is a valid tool for predicting neonatal hyperbilirubinemia.
  • It possesses good differentiation, calibration, and clinical applicability.
  • The nomogram can aid in the early identification of newborns at risk for hyperbilirubinemia.